News

R egeneron has received an US Food and Drug Administration (FDA) rejection for a new blood cancer therapy and expects ...
Moving on, Regeneron’s second-quarter report was largely positive. Total revenues of $3.68 billion (up 4% YoY) beat analyst ...
Regeneron Pharmaceuticals delivered strong Q2 results and made net progress with its commercial portfolio and pipeline. Click ...
That's what happened beginning in November of last year, anyway. The company announced solid testing results for VK2735. But ...
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...
Eli Lilly raised its full-year profit and sales forecast on Thursday, betting on surging demand for its blockbuster ...
A breakthrough has been made in weight-loss drugs after scientists discovered a new medication – known as TDP – that works without causing side effects of nausea or vomiting. Millions of ...
President Trump on Thursday sent letters to 17 of the world’s biggest drugmakers demanding that they reduce some of their U.S ...